title: Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function.
authors.affiliation: Victorian Liver Transplant Unit, Austin Hospital, Heidelberg, Australia.
authors.forename: I D
authors.initials: ID
authors.lastname: Michell
authors.forename: I
authors.initials: I
authors.lastname: Abdulnour
authors.forename: G
authors.initials: G
authors.lastname: Pzybylowski
authors.forename: J
authors.initials: J
authors.lastname: Bowkett
authors.forename: A
authors.initials: A
authors.lastname: Gleeson
authors.forename: K J
authors.initials: KJ
authors.lastname: Hardy
authors.forename: R M
authors.initials: RM
authors.lastname: Jones
mesh_terms: D005069:Evaluation Studies as Topic; D006801:Humans; D006820:Hyaluronic Acid / Q000097:blood*; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000097:blood; D008099:Liver / Q000293:injuries; D008111:Liver Function Tests / Q000379:methods*; D016031:Liver Transplantation / Q000502:physiology*; D009926:Organ Preservation / Q000009:adverse effects; D014019:Tissue Donors
chemical_list: D006820:Hyaluronic Acid; D008012:Lidocaine; C001173:monoethylglycinexylidide